Gilead Sciences (GILD) EBT (2009 - 2026)
Gilead Sciences' EBT came in at -$10.25 billion for Q2 2026, compared with $2.43 billion a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) EBT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gilead Sciences reported EBT of -$1.96 billion; for FY2025, it was $9.8 billion.
- EBT carries a five-year compound annual growth rate of 42.5% (FY2020 to FY2025).
- Going back by year, EBT was $690 million in FY2024 (-89.9%), $6.86 billion in FY2023 (+18.0%), $5.81 billion in FY2022 (-29.8%) and $8.28 billion in FY2021 (+396.0%).
- The Q2 2026 figure represents the lowest quarterly EBT in data going back to Q1 2009.
- Year-over-year, EBT increased in four of the last six quarters, with growth averaging 54.0%.
- The fastest year-over-year change in EBT over five years came in Q3 2021 (growth of 316.7%), and the weakest in Q3 2024 (a decline of 58.8%).
- Business Quant data shows GILD's EBT at $2.58 billion (Q1 2026), $2.08 billion (Q4 2025) and $3.64 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.65 Bn | 1,100.24 Bn | 19.71 Bn | 9.25 Bn |
| 2 | Johnson & Johnson | 615.89 Bn | 534.41 Bn | 17.26 Bn | 6.75 Bn |
| 3 | AbbVie | 505.03 Bn | 478.14 Bn | 12.70 Bn | 4.28 Bn |
| 4 | Merck | 368.78 Bn | 323.16 Bn | 12.21 Bn | -683.00 Mn |
| 5 | Novartis Ag | 298.66 Bn | 262.65 Bn | 11.24 Bn | 4.27 Bn |
| 6 | Astrazeneca | 262.09 Bn | 235.78 Bn | 12.86 Bn | 2.80 Bn |
| 7 | Amgen | 236.57 Bn | 191.97 Bn | 7.24 Bn | 2.77 Bn |
| 8 | Gilead Sciences | 191.05 Bn | 165.25 Bn | 6.22 Bn | -10.25 Bn |
| 9 | Pfizer | 170.60 Bn | 117.25 Bn | 10.94 Bn | -653.00 Mn |
| 10 | Vertex Pharmaceuticals | 131.36 Bn | 103.36 Bn | 2.84 Bn | 1.39 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.25 Bn |
| Mar 31, 2026 | 2.58 Bn |
| Dec 31, 2025 | 2.08 Bn |
| Sep 30, 2025 | 3.64 Bn |
| Jun 30, 2025 | 2.43 Bn |
| Mar 31, 2025 | 1.65 Bn |
| Dec 31, 2024 | 2.17 Bn |
| Sep 30, 2024 | 956.00 Mn |
| Jun 30, 2024 | 2.05 Bn |
| Mar 31, 2024 | -4.49 Bn |
| Dec 31, 2023 | 1.65 Bn |
| Sep 30, 2023 | 2.32 Bn |
| Jun 30, 2023 | 1.59 Bn |
| Mar 31, 2023 | 1.30 Bn |
| Dec 31, 2022 | 2.03 Bn |
| Sep 30, 2022 | 2.43 Bn |
| Jun 30, 2022 | 1.50 Bn |
| Mar 31, 2022 | -152.00 Mn |
| Dec 31, 2021 | 759.00 Mn |
| Sep 30, 2021 | 3.44 Bn |
API Access
Gilead Sciences EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();